合成线性RGD肽,Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline
  • 合成线性RGD肽,Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline

91037-75-1

价格 询价
包装 20mg 5mg 10mg
最小起订量 20mg
发货地 四川
更新日期 2024-06-14
QQ交谈 微信洽谈

产品详情

中文名称:合成线性RGD肽英文名称:Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline
CAS:91037-75-1品牌: 维克奇
保存条件: -20℃,干燥、避光、密封纯度规格: HPLC≥98%
产品类别: 标准品
2024-06-14 合成线性RGD肽 Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline 20mg/RMB;5mg/RMB;10mg/RMB 维克奇 -20℃,干燥、避光、密封 HPLC≥98% 标准品

WKQ-0014205

中文名称:合成线性RGD肽

中文别名:甘氨酰-精氨酰-甘氨酰-天冬氨酰-丝氨酰-脯氨酸

英文名称:Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline

英文别名:L-Proline, 1-[N-[N-[N-(N2-glycyl-L-arginyl)glycyl]-L-α-aspartyl]-L-seryl]-;Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline;103: PN: US20090257952 SEQID: 105 unclaimed protein;108: PN: WO2012045822 PAGE: 9 unclaimed sequence;10: PN: KR20170136178 PAGE: 3 claimed sequence;10: PN: WO2012124998 SEQID: 10 unclaimed protein;11: PN: EP2463301 SEQID: 1 claimed sequence;11: PN: WO2004087736 SEQID: 11 unclaimed sequence;11: PN: WO2010125722 SEQID: 2 unclaimed protein;126: PN: WO2008058016 SEQID: 127 claimed protein;12: PN: JP2003089648 SEQID: 13 unclaimed;12: PN: US20140004158 SEQID: 13 claimed sequence;12: PN: US6713606 SEQID: 13 unclaimed sequence;12: PN: WO0182944 SEQID: 2 unclaimed sequence;12: PN: WO2014123399 SEQID: 34 claimed protein;134: PN: US20120121709 SEQID: 133 unclaimed sequence;13: PN: WO2020198685 SEQID: 44 claimed protein;14: PN: JP2004000070 SEQID: 16 unclaimed protein;14: PN: US20130052712 SEQID: 15 claimed protein;14: PN: WO03076596 SEQID: 14 unclaimed sequence;15: PN: KR20090132815 PAGE: 3 claimed sequence;15: PN: KR20090132911 SEQID: 110 claimed protein;15: PN: KR20160113372 SEQID: 15 claimed sequence;15: PN: KR20160129982 SEQID: 15 claimed sequence;15: PN: US6710030 SEQID: 15 unclaimed sequence;15: PN: WO2011025158 SEQID: 15 claimed sequence;16: PN: EP2455104 SEQID: 18 claimed protein;16: PN: JP2003210166 SEQID: 16 unclaimed protein;16: PN: JP2004049921 SEQID: 16 unclaimed protein;16: PN: US20190070313 SEQID: 16 claimed sequence;16: PN: WO2012065751 SEQID: 18 claimed protein;16: PN: WO2019046937 SEQID: 16 claimed protein;17: PN: KR20120114072 SEQID: 15 unclaimed protein;17: PN: WO2017171001 SEQID: 22 claimed protein;17: PN: WO2021231383 SEQID: 17 claimed protein;18: PN: JP2006087396 SEQID: 1 unclaimed protein;18: PN: WO2016022851 SEQID: 72 claimed protein;199: PN: WO2017040335 SEQID: 212 claimed protein;19: PN: US20090191645 SEQID: 19 unclaimed sequence;19: PN: US20120003201 SEQID: 17 claimed sequence;19: PN: WO2006089678 SEQID: 19 unclaimed sequence;1: PN: CN102145194 SEQID: 1 claimed sequence;1: PN: JP2009100679 SEQID: 1 unclaimed protein;1: PN: US20030059865 PAGE: 6 claimed protein;1: PN: US20110008443 SEQID: 1 claimed protein;1: PN: WO0025583 PAGE: 17 unclaimed sequence;1: PN: WO0226939 SEQID: 1 claimed protein;1: PN: WO2012060607 SEQID: 1 claimed protein;1: PN: WO2017009200 SEQID: 1 claimed protein;1: PN: WO2020198695 SEQID: 49 claimed protein;1: PN: WO2022164931 SEQID: 34 claimed sequence;1: PN: WO2022170098 PAGE: 88 claimed sequence;20: PN: US20200370021 SEQID: 36 claimed protein;212: PN: US20170253888 SEQID: 212 claimed protein;212: PN: WO2022006368 SEQID: 212 claimed protein;21: PN: US20080038274 SEQID: 26 claimed sequence;228: PN: WO2021146455 SEQID: 301 claimed protein;22: PN: KR20140027031 SEQID: 23 claimed protein;23: PN: WO2022027020 PAGE: 57 claimed sequence;24: PN: US5981478 SEQID: 21 unclaimed sequence;2: PN: EP967276 SEQID: 4 unclaimed protein;2: PN: JP2004000471 SEQID: 16 unclaimed protein;2: PN: US20160355780 SEQID: 16 claimed protein;2: PN: US7141551 SEQID: 2 unclaimed sequence;2: PN: US7629115 SEQID: 2 unclaimed sequence;2: PN: WO2006036962 SEQID: 2 unclaimed protein;2: PN: WO2010033249 SEQID: 2 unclaimed protein;2: PN: WO2018105777 PAGE: 49 claimed sequence;2: PN: WO2021237295 PAGE: 42 claimed sequence;30: PN: WO2022212720 SEQID: 37 claimed protein;31: PN: US20050059585 SEQID: 31 unclaimed sequence;31: PN: US7521540 SEQID: 31 unclaimed sequence;31: PN: WO0155210 SEQID: 31 unclaimed sequence;32: PN: US20070161570 SEQID: 31 unclaimed sequence;33: PN: DE102008060991 PAGE: 9/20 claimed protein;33: PN: DE102008060992 TABLE: 1 claimed protein;33: PN: US20050002904 SEQID: 11 claimed sequence;33: PN: WO2005021593 PAGE: 24 claimed sequence;34: PN: US20020160954 SEQID: 32 unclaimed;34: PN: US6790606 SEQID: 31 unclaimed sequence;37: PN: US20020160954 SEQID: 35 unclaimed;38: PN: US6521211 SEQID: 3 unclaimed sequence;3: PN: US20060153775 SEQID: 3 unclaimed sequence;3: PN: US20140005356 SEQID: 15 claimed sequence;3: PN: WO2008023378 SEQID: 3 unclaimed sequence;3: PN: WO2014172355 SEQID: 3 claimed protein;40: PN: US6004782 SEQID: 19 unclaimed sequence;42: PN: WO2004101799 SEQID: 43 unclaimed sequence;461: PN: WO0069900 SEQID: 1146 unclaimed sequence;470: PN: WO0069900 SEQID: 1156 unclaimed sequence;4: PN: JP2002281964 SEQID: 20 unclaimed sequence;4: PN: JP2006249031 SEQID: 4 claimed protein;4: PN: KR20140129467 SEQID: 4 claimed protein;4: PN: US20160271151 PAGE: 15 claimed sequence;4: PN: WO0062815 PAGE: 19 unclaimed sequence;4: PN: WO2008127675 SEQID: 4 unclaimed sequence;4: PN: WO2009054128 SEQID: 1 unclaimed sequence;4: PN: WO2019172358 SEQID: 4 claimed protein;4: PN: WO2021123799 SEQID: 4 claimed protein;51: PN: WO2014042463 SEQID: 52 unclaimed protein;55: PN: US20060078535 SEQID: 83 unclaimed sequence;64: PN: US20080032928 PAGE: 53 claimed protein;66: PN: US6955900 SEQID: 66 unclaimed protein;6: PN: JP2002320666 SEQID: 20 unclaimed sequence;6: PN: JP2012126720 SEQID: 6 unclaimed protein;6: PN: US6193981 SEQID: 5 unclaimed sequence;6: PN: WO2004110477 PAGE: 3 unclaimed sequence;6: PN: WO2022026606 SEQID: 54 claimed protein;71: PN: JP2007051127 SEQID: 67 unclaimed protein;7: PN: JP2010159217 SEQID: 7 unclaimed protein;7: PN: JP2011139839 PAGE: 11 unclaimed sequence;82: PN: WO2008134544 SEQID: 87 unclaimed protein;83: PN: US20120014925 SEQID: 83 unclaimed sequence;83: PN: US6001965 SEQID: 83 claimed protein;83: PN: WO2012008967 SEQID: 83 unclaimed sequence;89: PN: WO2008113030 SEQID: 90 unclaimed sequence;8: PN: JP2008067616 SEQID: 21 claimed protein;8: PN: JP2011229661 PAGE: 9 unclaimed sequence;8: PN: KR20160026441 SEQID: 23 claimed protein;8: PN: US20020193298 SEQID: 31 unclaimed sequence;8: PN: WO0214488 SEQID: 7 unclaimed sequence;900: PN: US20090175821 SEQID: 1146 claimed protein;9: PN: KR20150027940 SEQID: 10 claimed protein;9: PN: US20150064143 SEQID: 9 claimed sequence;9: PN: WO0004941 PAGE: 31 claimed sequence;

分子式:C22H37N9O10

分子量:587.58

CAS号:91037-75-1

纯度:HPLC≥98%

密度:1.65±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr

酸系度数:3.31±0.20 | Condition: Most Acidic Temp: 25 °C

储存条件:-20℃,干燥、避光、密封

规格:5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装

供应单位:四川省维克奇生物科技有限公司

供应电话:028-81700200/4008005713

四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体,主打中药对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等,敬请关注!    新批次有现货,欢迎咨询。


 




关键字: 91037-75-1;

公司简介

成都彼样生物科技有限公司是四川省成都市一家专业从事天然药物纯化分离,集生产研发/销售于一体的公司。公司名下有四家公司“成都标样生物科技有限公司,成都超九八生物科技有限公司,四川省维克奇生物科技有限公司”。   2014年我公司与中国科学院成都生物研究所共建联合实验室,主打中药对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。实验室拥有一批精密的分离纯化系统和检测设备;拥有一批技术精湛的研究队伍;拥有一套完整的质量管理体系;   公司可承接以下业务:   1、指定化合物克级---公斤级定制业务;   2、指定药材全系列的分离纯化业务;   3、新化合物的分离纯化及结构鉴定业务;   4、指
成立日期 2016-09-09 (8年) 注册资本 100000
员工人数 10-50人 年营业额 ¥ 100万-300万
主营行业 化学试剂,高纯试剂 经营模式 试剂
  • 成都彼样生物科技有限公司
VIP 6年
  • 公司成立:8年
  • 注册资本:100000
  • 企业类型:有限责任公司
  • 主营产品:甘草系列、人参系列、补骨脂系列、雷公藤系列、银杏系列、黄芪皂苷系列、黄芩系列、柴胡系列、酸枣仁系列、重楼系列、五味子系列、大黄系列、丹参系列、柴胡系列、远志系列、平贝系列等
  • 公司地址:青羊区日月大道一段978号青羊万达3幢1单元1632
询盘

91037-75-1相关厂家报价

更多
产品名称 价格   公司名称 报价日期
¥69
VIP3年
绍兴市均宇生物科技有限公司
2024-06-15
询价
VIP4年
杭州固拓生物科技有限公司
2024-06-15
询价
VIP2年
上海鸿肽生物科技有限公司
2024-05-06
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.
400-158-6606